General Information of the Compound
Compound ID
CP0431256
Compound Name
2-methyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]benzamide
    Show/Hide
Structure
Formula
C20H31N3O
Molecular Weight
329.488
Canonical SMILES
CN1CCN(CC1)C1(CNC(=O)c2ccccc2C)CCCCC1
    Show/Hide
InChI
InChI=1S/C20H31N3O/c1-17-8-4-5-9-18(17)19(24)21-16-20(10-6-3-7-11-20)23-14-12-22(2)13-15-23/h4-5,8-9H,3,6-7,10-16H2,1-2H3,(H,21,24)
    Show/Hide
InChIKey
NZHBNMWPBRFNFV-UHFFFAOYSA-N
Physicochemical Property
logP
2.67512
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
35.58
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56665614
ChEMBL ID
CHEMBL1823678
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05165, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 63095.73 nM
   TI
   LI
   LO
   TS